Ovarian function suppression (OFS) has become a key component of endocrine therapy for premenopausal women with hormone receptor positive breast cancer, significantly influencing long-term disease outcomes. This CME/CE activity reviews the evolving role of OFS in modern breast cancer management, integrating recommendations from ASCO, NCCN, and ESMO guidelines with long-term data from landmark trials such as SOFT, TEXT, and HOBOE. Faculty will discuss practical considerations, including optimal timing of initiation, duration of therapy, and the clinical implications of monthly versus every-three-month GnRH agonist dosing. The program also addresses challenges such as interpreting estradiol levels, managing treatment-related adverse effects, and balancing efficacy with patient quality of life. Through multidisciplinary perspectives from oncology, cardio-oncology, and survivorship care, participants will learn strategies to personalize OFS therapy, improve adherence, and support holistic, patient-centered care for young women with early-stage breast cancer.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 50 Division Street
Pricing
CME included with membership
| Free CME Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Clinical Informatics
- Dermatology
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Pediatric Neurology
- Sleep Medicine
- Surgical Oncology
- Urological Oncology
- Vascular Neurology
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedFeb 2, 2026
-
Last day to claim creditFeb 3, 2027 4 months left
-
eMedEd Genetic Predisposition for Breast Cancer & Management of BRCA1/2 Mutation Carriers
-
eMedEd Bladder Cancer in Young Women: Unique Challenges and Fertility Preservation
-
eMedEd Advancements in HPV-Related Cancer Prevention and Treatment: Integrating Vaccination, Screening, and Therapeutic Innovations
